Capital Change Notice – Ordinary Shares

Template
Capital Change Notice

Updated as at 17 October 2019



Section 1: Issuer information
Name of issuer Rua Bioscience Limited
NZX ticker code RUA
Class of financial product Equity Security (ordinary
shares)
ISIN (If unknown, check on NZX website) NZRUAE0004S1
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed 8,140,000
Nominal value (if any) N/A
Issue/acquisition/redemption price per security N/A
Nature of the payment (for example, cash or other
consideration)
Other consideration
Amount paid up (if not in full) Paid up in full
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the number of
Financial Products of the Class, excluding any Treasury Stock,
in existence)
1

5.74%
For an issue of Convertible Financial Products or Options, the
principal terms of Conversion (for example the Conversion
price and Conversion date and the ranking of the Financial
Product in relation to other Classes of Financial Product) or the
Option (for example, the exercise price and exercise date)
N/A
Reason for issue/acquisition/redemption and specific authority
for issue/acquisition/redemption/ (the reason for change must
be identified here)
Acquisition of Zalm
Therapeutics Limited
Total number of Financial Products of the Class after the
issue/acquisition/redemption/Conversion (excluding Treasury
Stock) and the total number of Financial Products of the Class
held as Treasury Stock after the issue/acquisition/redemption.
149,879,267
In the case of an acquisition of shares, whether those shares
are to be held as treasury stock
N/A
Specific authority for the issue, acquisition, or redemption,
including a reference to the rule pursuant to which the issue,
acquisition, or redemption is made
Shareholder Resolution dated
19 January 2022 and
Directors' resolution and
Directors'' certificate dated on
our about the date of issue
Listing Rules 4.6.1 and
5.2.2(e)

1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)
N/A
Date of issue/acquisition/redemption
2
04/02/2022
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this announcement Hamish White
Contact person for this announcement Kerry Donovan
Contact phone number
Contact email address Kerry.donovan@ruabio.com
Date of release through MAP

02/02/2022




2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).